Duobrii in Combination With Biologics

Inclusion Criteria:

Male or female adult ≥ 18 years of age;
Diagnosis of chronic plaque-type
Psoriasis affecting 2%-10% BSA
Patient is being treated with biologic therapy for a minimum of 24 weeks
Able and willing to give written informed consent prior to performance of any study-related procedures

Exclusion Criteria:

Psoriasis affecting Ë‚2% or >10% BSA
Patient not receiving a biologic agent, or receiving biologic agent <24weeks
Received treatment with any topical antipsoriatic drug product within 14 days prior to the Baseline visit.
Has previously used DUOBRII